Filing Details
- Accession Number:
- 0001140361-13-040786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-06 08:31:53
- Reporting Period:
- 2013-11-04
- Filing Date:
- 2013-11-06
- Accepted Time:
- 2013-11-06 08:31:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377232 | Phd J Michael Williams | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-04 | 3,834 | $53.31 | 13,642 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-04 | 3,942 | $56.95 | 17,584 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-04 | 2 | $34.37 | 17,586 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-04 | 6,020 | $108.19 | 11,566 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-04 | 3,834 | $0.00 | 3,834 | $53.31 |
| Common Stock | Non-Qualified Stock Options (right to buy) | Disposition | 2013-11-04 | 2,186 | $0.00 | 2,186 | $56.95 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-11-04 | 1,756 | $0.00 | 1,756 | $56.95 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-11-04 | 2 | $0.00 | 2 | $34.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,793 | 2017-02-13 | No | 4 | M | Direct | |
| 0 | 2015-02-13 | No | 4 | M | Direct | |
| 0 | 2015-02-13 | No | 4 | M | Direct | |
| 2,909 | 2016-02-13 | No | 4 | M | Direct |
Footnotes
- Includes 54 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2013.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $108.0200 to $108.4400, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of options to buy shares of common stock becomes exercisable as to 3,834 shares on 02/14/2011, 02/14/2012, 02/14/2013 and 02/14/2014 and the remaining 1,959 shares on 02/14/2015.
- Grant of options to buy shares of common stock becomes exercisable as to 3,942 shares on 02/14/2009, 3,941 shares on 02/14/2010 and 02/14/2012, 3,940 shares on 02/14/2011 and the remaining 2,186 shares on 02/14/2013.
- Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011 and the remaining 1,755 shares on 02/14/2013.
- Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2010 and 02/14/2013 and the remaining 2,909 shares on 02/14/2014.
Billionaire Hedge Funds
